高分子量激肽原(HMWK)多克隆抗体
Polyclonal Antibody to High Molecular Weight Kininogen (HMWK)
Williams-Fitzgerald-Flaujeac Factor; Fitzgerald Factor; HMWK-Kallikrein Factor
- 编号PAB805Hu02
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPB805Hu02-高分子量激肽原(HMWK)重组蛋白
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度1mg/ml
- 且适物种Sus scrofa; Porcine (Pig,猪)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 598 ¥ 1394 ¥ 1992 ¥ 4980 ¥ 19920
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对HMWK的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别HMWK。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPB805Hu01 | 高分子量激肽原(HMWK)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB805Hu02 | 高分子量激肽原(HMWK)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB805Hu01 | 高分子量激肽原(HMWK)多克隆抗体 | WB; IHC; ICC; IP. |
PAB805Hu02 | 高分子量激肽原(HMWK)多克隆抗体 | WB; IHC; ICC; IP. |
LAB805Hu71 | 高分子量激肽原(HMWK)多克隆抗体(生物素标记) | WB; IHC; ICC. |
SEB805Hu | 高分子量激肽原(HMWK)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB805Hu | 高分子量激肽原(HMWK)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB805Hu | 高分子量激肽原(HMWK)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Thromb Res | Factor XII–mediated contact activation related to poor prognosis in disseminated intravascular coagulation [PubMed: 26706311] |
Thrombosis Research | Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coaCavia (Guinea pig )lation [Pubmed:26706311] |
european journal of endocrinology | Contact system activation and high thrombin generation in hyperthyroidism. [pubmed:28137735] |
J Thromb Thrombolysis | Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors [Pubmed:34993714] |
留言咨询